- Report
- November 2024
United Kingdom
From €2081EUR$2,095USD£1,730GBP
€3964EUR$3,990USD£3,296GBP
- Report
- November 2024
North America
From €2081EUR$2,095USD£1,730GBP
€3964EUR$3,990USD£3,296GBP
- Report
- November 2024
Europe
From €2081EUR$2,095USD£1,730GBP
€3964EUR$3,990USD£3,296GBP
- Report
- November 2024
Middle East
From €2081EUR$2,095USD£1,730GBP
€3964EUR$3,990USD£3,296GBP
- Report
- November 2024
Asia Pacific
From €2081EUR$2,095USD£1,730GBP
€3964EUR$3,990USD£3,296GBP
- Report
- November 2024
Global
From €2081EUR$2,095USD£1,730GBP
€3964EUR$3,990USD£3,296GBP
- Report
- October 2023
- 80 Pages
Vietnam
From €1490EUR$1,500USD£1,239GBP
- Report
- October 2023
- 80 Pages
United States
From €1490EUR$1,500USD£1,239GBP
- Report
- October 2023
- 80 Pages
Russia
From €1490EUR$1,500USD£1,239GBP
- Report
- October 2023
- 80 Pages
Poland
From €1490EUR$1,500USD£1,239GBP
- Report
- October 2023
- 80 Pages
Japan
From €1490EUR$1,500USD£1,239GBP
- Report
- October 2023
- 80 Pages
Ireland
From €1490EUR$1,500USD£1,239GBP
- Report
- October 2023
- 80 Pages
Brazil
From €1490EUR$1,500USD£1,239GBP
- Report
- October 2023
- 80 Pages
Argentina
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
Argentina
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
Vietnam
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
United States
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
United Kingdom
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
Poland
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2023
- 80 Pages
Japan
From €1490EUR$1,500USD£1,239GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more